Review
Open access
Jul 2026
CRISPR/Cas9 in cancer therapy: clinical translation, mechanistic strategies, and therapeutic directions
Overall, CRISPR/Cas9 represents a promising yet evolving platform in oncology, with its future clinical success dependent on achieving a balance between precision, safety, scalability, and long-term therapeutic durability.
C. Ng, Sakina Mustafa, X. Y. Yap et al.
· Frontiers in Oncology · 0 citations